Clinical Trials Browser

Phase 1 × Melanoma × Interleukin-12 × Clear all

NCT01457131 2019-01-08

Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer

Phase 1 Terminated

DermatologicGenitourinary

Kidney Neoplasms, Melanoma, Neoplasm Metastasis